TABLE 1.
Percentages of GFP- or LT-positive cells in dermal fibroblasts treated with MCPyV pseudovirus, MCPyV, or MCPyV chimeric viruses
Source of fibroblasts | % of GFP+ fibroblasts (mean ± SEMa) following exposure to MCPyV-GFP | % of LT+ fibroblasts (mean ± SEMa) following exposure to: |
|||
---|---|---|---|---|---|
MCPyV | MCPyV-MuPyV | MCPyV-SV40 A | MCPyV-SV40 B | ||
Human | 15.13 ± 7.49 | 40.17 ± 4.80 | 4.00 ± 1.61 | 21.80 ± 3.39 | 33.33 ± 5.64 |
Mouse | 0.87 ± 0.23 | 0 | <0.01 | 0.07 ± 0.02 | 0.13 ± 0.04 |
Rabbit | 46.30 ± 8.32 | 0 | 0.12 ± 0.04 | <0.01 | 0.57 ± 0.23 |
Rat | 33.33 ± 5.76 | 5.80 ± 2.48 | 3.17 ± 1.13 | 3.83 ± 1.10 | 52.77 ± 6.68 |
Chimpanzee | 47.17 ± 9.59 | 43.67 ± 4.60 | NA | NA | NA |
Rhesus macaque | 31.50 ± 6.37 | 0.81 ± 0.17 | 0.67 ± 0.32 | 3.16 ± 1.01 | 16.43 ± 5.57 |
Patas monkey | 15.63 ± 3.23 | 0.40 ± 0.15 | NA | NA | NA |
Common woolly monkey | 10.40 ± 2.58 | 0 | NA | NA | NA |
Red-chested mustached tamarin | 9.47 ± 2.12 | 0 | NA | NA | NA |
Tree shrew | 3.83 ± 1.34 | 0 | NA | NA | NA |
Data are from the results of at least three independent experiments. NA, not applicable.